Citius Pharmaceuticals, Inc. Notes Payable, Current
Citius Pharmaceuticals, Inc. (CTXR) had Notes Payable, Current of $1.00 million as of 2025-12-31, per its 10-Q filed 2026-02-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:NotesPayableCurrent · last filed 2026-08-14
- 2025-12-31: Notes Payable, Current $1.00M.
- 2025-09-30: Notes Payable, Current $1.00M.
- 2025-06-30: Notes Payable, Current $1.00M.
- 2025-06-02: Notes Payable, Current $1.00M.
| Period end | Notes Payable, Current |
|---|---|
| 2025-12-31 | $1.00M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $1.00M 10-Q · filed 2026-08-14 |
| 2025-06-30 | $1.00M 10-Q · filed 2025-08-12 |
| 2025-06-02 | $1.00M 10-Q · filed 2026-05-15 |
| 2021-03-31 | $172.97K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $172.97K 10-Q · filed 2021-02-11 |
| 2020-09-30 | $172.97K 10-K · filed 2021-12-15 |
| 2020-06-30 | $172.97K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $172.97K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $172.97K 10-Q · filed 2020-02-13 |
| 2019-09-30 | $172.97K 10-K · filed 2020-12-16 |
| 2019-06-30 | $172.97K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $172.97K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $172.97K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $172.97K 10-K · filed 2019-12-16 |
| 2018-06-30 | $172.97K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $172.97K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $172.97K 10-Q · filed 2018-02-14 |
| 2017-09-30 | $172.97K 10-K · filed 2018-12-11 |
| 2017-06-30 | $5.42M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $2.02M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $1.49M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $672.97K 10-K · filed 2017-12-13 |
| 2016-06-30 | $172.97K 10-Q · filed 2016-08-15 |
| 2014-06-30 | $29.20K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $24.21K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $20.72K 10-Q · filed 2014-02-19 |
| 2013-09-30 | $3.20K 10-Q · filed 2014-08-14 |
| 2013-06-30 | $51.84K 10-Q · filed 2013-09-18 |
| 2013-03-31 | $26.95K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $17.25K 10-Q · filed 2013-02-08 |
| 2012-09-30 | $17.05K 10-K · filed 2014-02-06 |
| 2012-06-30 | $2.94K 10-Q · filed 2012-08-17 |
| 2011-09-30 | $0.00 10-K · filed 2013-01-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |